New

Ivermectin Medication Market

2021

Ivermectin Medication Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Route of Administration (Orals, Injector); Indication (Onchocerciasis, Ascariasis, Strongyloidiasis, Intestinal Parasites Disease, lymphatic Filariasis, Others); Application (human use, veterinary use)

| Report Code: TIPRE00013506 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Ivermectin Medication Market 2028 By Route of Administration, Indication, Application | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Ivermectin belongs to the class of anthelmintic drugs. They are commonly used in the diagnosis of roundworm parasite infections. The drugs are used to kill parasites, and thus improve patients ' quality of life. Ivermectin is also recommended for river blindness (onchocerciasis) and diarrhea (strongyloidiasis) treatment. It paralyzes and kills the offspring, thereby slowing down the rate of adult worm reproduction, which results in the minimal presence of worms in skin, blood, and eyes. Other parasitic infections treated with ivermectin are lymphatic filariasis, scabies, trichuriasis, and ascariasis. Ivermectin drugs are used for both human and veterinary use.

MARKET DYNAMICS

The Ivermectin Medication market is expected to grow significantly in the coming years, due to rise in prevalence of parasitic infections such as ascariasis, lymphatic filariasis, and river blindness. Moreover, increasing research studies in SARS-CoV-2-virus as antiviral properties anticipated to influence the end-user of Ivermectin.

MARKET SCOPE

The "Ivermectin Medication Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Ivermectin Medication market with detailed market segmentation by route of administration, indication, application and indication. The Ivermectin Medication market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Ivermectin Medication market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Ivermectin Medication market is segmented on the basis of route of administration, indication, application and indication. Based on route of administration, the market is segmented into orals, Injector. On the basis of indications, the market is categorized as Onchocerciasis, Ascariasis, Strongyloidiasis, Intestinal Parasites Disease, lymphatic Filariasis, Others. On the basis of application, the market is categorized as human use, veterinary use.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Ivermectin Medication market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Ivermectin Medication market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Ivermectin Medication market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Ivermectin Medication market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Ivermectin Medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Ivermectin Medication market are anticipated to have lucrative growth opportunities in the future with the rising demand for Ivermectin Medication in the global market. Below mentioned is the list of few companies engaged in the Ivermectin Medication market.

The report also includes the profiles of key players in Ivermectin Medication market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Novartis AG
  •   Intas Pharmaceuticals
  •   Boehringer Ingelheim International GmbH
  •   Cipla, Inc.
  •   Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  •   Sun Pharmaceutical Industries Ltd.
  •   GlaxoSmithKline plc
  •   Merck & Co., Inc.
  •   Bayer AG
  •   Arbor Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ivermectin Medication Market - By Route of Administration
1.3.2 Ivermectin Medication Market - By Indication
1.3.3 Ivermectin Medication Market - By Application
1.3.4 Ivermectin Medication Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IVERMECTIN MEDICATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IVERMECTIN MEDICATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IVERMECTIN MEDICATION MARKET - GLOBAL MARKET ANALYSIS
6.1. IVERMECTIN MEDICATION - GLOBAL MARKET OVERVIEW
6.2. IVERMECTIN MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. IVERMECTIN MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
7.1. OVERVIEW
7.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
7.3. ORALS
7.3.1. Overview
7.3.2. Orals Market Forecast and Analysis
7.4. INJECTOR
7.4.1. Overview
7.4.2. Injector Market Forecast and Analysis
8. IVERMECTIN MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCHOCERCIASIS
8.3.1. Overview
8.3.2. Onchocerciasis Market Forecast and Analysis
8.4. ASCARIASIS
8.4.1. Overview
8.4.2. Ascariasis Market Forecast and Analysis
8.5. STRONGYLOIDIASIS
8.5.1. Overview
8.5.2. Strongyloidiasis Market Forecast and Analysis
8.6. INTESTINAL PARASITES DISEASE
8.6.1. Overview
8.6.2. Intestinal Parasites Disease Market Forecast and Analysis
8.7. LYMPHATIC FILARIASIS
8.7.1. Overview
8.7.2. lymphatic Filariasis Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. IVERMECTIN MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. HUMAN USE
9.3.1. Overview
9.3.2. human use Market Forecast and Analysis
9.4. VETERINARY USE
9.4.1. Overview
9.4.2. veterinary use Market Forecast and Analysis
10. IVERMECTIN MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Ivermectin Medication Market Overview
10.1.2 North America Ivermectin Medication Market Forecasts and Analysis
10.1.3 North America Ivermectin Medication Market Forecasts and Analysis - By Route of Administration
10.1.4 North America Ivermectin Medication Market Forecasts and Analysis - By Indication
10.1.5 North America Ivermectin Medication Market Forecasts and Analysis - By Application
10.1.6 North America Ivermectin Medication Market Forecasts and Analysis - By Countries
10.1.6.1 United States Ivermectin Medication Market
10.1.6.1.1 United States Ivermectin Medication Market by Route of Administration
10.1.6.1.2 United States Ivermectin Medication Market by Indication
10.1.6.1.3 United States Ivermectin Medication Market by Application
10.1.6.2 Canada Ivermectin Medication Market
10.1.6.2.1 Canada Ivermectin Medication Market by Route of Administration
10.1.6.2.2 Canada Ivermectin Medication Market by Indication
10.1.6.2.3 Canada Ivermectin Medication Market by Application
10.1.6.3 Mexico Ivermectin Medication Market
10.1.6.3.1 Mexico Ivermectin Medication Market by Route of Administration
10.1.6.3.2 Mexico Ivermectin Medication Market by Indication
10.1.6.3.3 Mexico Ivermectin Medication Market by Application
10.2. EUROPE
10.2.1 Europe Ivermectin Medication Market Overview
10.2.2 Europe Ivermectin Medication Market Forecasts and Analysis
10.2.3 Europe Ivermectin Medication Market Forecasts and Analysis - By Route of Administration
10.2.4 Europe Ivermectin Medication Market Forecasts and Analysis - By Indication
10.2.5 Europe Ivermectin Medication Market Forecasts and Analysis - By Application
10.2.6 Europe Ivermectin Medication Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Ivermectin Medication Market
10.2.6.1.1 Germany Ivermectin Medication Market by Route of Administration
10.2.6.1.2 Germany Ivermectin Medication Market by Indication
10.2.6.1.3 Germany Ivermectin Medication Market by Application
10.2.6.2 France Ivermectin Medication Market
10.2.6.2.1 France Ivermectin Medication Market by Route of Administration
10.2.6.2.2 France Ivermectin Medication Market by Indication
10.2.6.2.3 France Ivermectin Medication Market by Application
10.2.6.3 Italy Ivermectin Medication Market
10.2.6.3.1 Italy Ivermectin Medication Market by Route of Administration
10.2.6.3.2 Italy Ivermectin Medication Market by Indication
10.2.6.3.3 Italy Ivermectin Medication Market by Application
10.2.6.4 Spain Ivermectin Medication Market
10.2.6.4.1 Spain Ivermectin Medication Market by Route of Administration
10.2.6.4.2 Spain Ivermectin Medication Market by Indication
10.2.6.4.3 Spain Ivermectin Medication Market by Application
10.2.6.5 United Kingdom Ivermectin Medication Market
10.2.6.5.1 United Kingdom Ivermectin Medication Market by Route of Administration
10.2.6.5.2 United Kingdom Ivermectin Medication Market by Indication
10.2.6.5.3 United Kingdom Ivermectin Medication Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Ivermectin Medication Market Overview
10.3.2 Asia-Pacific Ivermectin Medication Market Forecasts and Analysis
10.3.3 Asia-Pacific Ivermectin Medication Market Forecasts and Analysis - By Route of Administration
10.3.4 Asia-Pacific Ivermectin Medication Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Ivermectin Medication Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Ivermectin Medication Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Ivermectin Medication Market
10.3.6.1.1 Australia Ivermectin Medication Market by Route of Administration
10.3.6.1.2 Australia Ivermectin Medication Market by Indication
10.3.6.1.3 Australia Ivermectin Medication Market by Application
10.3.6.2 China Ivermectin Medication Market
10.3.6.2.1 China Ivermectin Medication Market by Route of Administration
10.3.6.2.2 China Ivermectin Medication Market by Indication
10.3.6.2.3 China Ivermectin Medication Market by Application
10.3.6.3 India Ivermectin Medication Market
10.3.6.3.1 India Ivermectin Medication Market by Route of Administration
10.3.6.3.2 India Ivermectin Medication Market by Indication
10.3.6.3.3 India Ivermectin Medication Market by Application
10.3.6.4 Japan Ivermectin Medication Market
10.3.6.4.1 Japan Ivermectin Medication Market by Route of Administration
10.3.6.4.2 Japan Ivermectin Medication Market by Indication
10.3.6.4.3 Japan Ivermectin Medication Market by Application
10.3.6.5 South Korea Ivermectin Medication Market
10.3.6.5.1 South Korea Ivermectin Medication Market by Route of Administration
10.3.6.5.2 South Korea Ivermectin Medication Market by Indication
10.3.6.5.3 South Korea Ivermectin Medication Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Ivermectin Medication Market Overview
10.4.2 Middle East and Africa Ivermectin Medication Market Forecasts and Analysis
10.4.3 Middle East and Africa Ivermectin Medication Market Forecasts and Analysis - By Route of Administration
10.4.4 Middle East and Africa Ivermectin Medication Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Ivermectin Medication Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Ivermectin Medication Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Ivermectin Medication Market
10.4.6.1.1 South Africa Ivermectin Medication Market by Route of Administration
10.4.6.1.2 South Africa Ivermectin Medication Market by Indication
10.4.6.1.3 South Africa Ivermectin Medication Market by Application
10.4.6.2 Saudi Arabia Ivermectin Medication Market
10.4.6.2.1 Saudi Arabia Ivermectin Medication Market by Route of Administration
10.4.6.2.2 Saudi Arabia Ivermectin Medication Market by Indication
10.4.6.2.3 Saudi Arabia Ivermectin Medication Market by Application
10.4.6.3 U.A.E Ivermectin Medication Market
10.4.6.3.1 U.A.E Ivermectin Medication Market by Route of Administration
10.4.6.3.2 U.A.E Ivermectin Medication Market by Indication
10.4.6.3.3 U.A.E Ivermectin Medication Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Ivermectin Medication Market Overview
10.5.2 South and Central America Ivermectin Medication Market Forecasts and Analysis
10.5.3 South and Central America Ivermectin Medication Market Forecasts and Analysis - By Route of Administration
10.5.4 South and Central America Ivermectin Medication Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Ivermectin Medication Market Forecasts and Analysis - By Application
10.5.6 South and Central America Ivermectin Medication Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Ivermectin Medication Market
10.5.6.1.1 Brazil Ivermectin Medication Market by Route of Administration
10.5.6.1.2 Brazil Ivermectin Medication Market by Indication
10.5.6.1.3 Brazil Ivermectin Medication Market by Application
10.5.6.2 Argentina Ivermectin Medication Market
10.5.6.2.1 Argentina Ivermectin Medication Market by Route of Administration
10.5.6.2.2 Argentina Ivermectin Medication Market by Indication
10.5.6.2.3 Argentina Ivermectin Medication Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IVERMECTIN MEDICATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. IVERMECTIN MEDICATION MARKET, KEY COMPANY PROFILES
13.1. NOVARTIS AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. INTAS PHARMACEUTICALS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CIPLA, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. JANSSEN PHARMACEUTICALS, INC. (JOHNSON AND JOHNSON)
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SUN PHARMACEUTICAL INDUSTRIES LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GLAXOSMITHKLINE PLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK AND CO., INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BAYER AG
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ARBOR PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Intas Pharmaceuticals
3. Boehringer Ingelheim International GmbH
4. Cipla, Inc.
5. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
6. Sun Pharmaceutical Industries Ltd.
7. GlaxoSmithKline plc
8. Merck & Co., Inc.
9. Bayer AG
10. Arbor Pharmaceuticals
TIPRE00013506
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.